ArticleNeuropsychopharmacology reports2022

Development and acceptability of a decision aid for major depressive disorder considering discontinuation of antidepressant treatment after remission.

Yumi Aoki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.